These findings provide new insights that increase our understanding of the molecular mechanisms involved in the development of HBV-associated HCC via the miR-30e-5p/MAPK/NFAT5/DARS2 pathway. The gene discussed is DARS2; the disease is hepatocellular carcinoma.